From the NORML website:
Rockville, MD: The US Food and Drug Administration (FDA) this week re-approved a synthetic cannabinoid analogue for prescription use in the United States.
The oral pill, marketed as Cesamet (also known as naboline), is an analogue (a structural derivative) of the cannabinoid THC. It will be available as a Schedule II controlled substance for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional anti-emetic treatments.
Read the full text here
Small steps in what I consider the right direction. Other countries (hello Kevin Rudd and Nicola Roxon) should be looking at what progress is being made in The States in regards to medicinal uses for Cannabis.
Posts
0 comments:
Post a Comment